Doris Duke Charitable Foundation Fund to Retain Clinical Scientists: innovating support for early-career family caregivers
Reshma Jagsi, … , Carrie Patton, Sindy Escobar Alvarez
Reshma Jagsi, … , Carrie Patton, Sindy Escobar Alvarez
Published December 1, 2022
Citation Information: J Clin Invest. 2022;132(23):e166075. https://doi.org/10.1172/JCI166075.
View: Text | PDF
Viewpoint

Doris Duke Charitable Foundation Fund to Retain Clinical Scientists: innovating support for early-career family caregivers

Abstract

Authors

Reshma Jagsi, T. DeLene Beeland, Kevin Sia, Lauren A. Szczygiel, Matthew R. Allen, Vineet M. Arora, Megan Bair-Merritt, Melissa D. Bauman, Hillary R. Bogner, Gail Daumit, Esa Davis, Angela Fagerlin, Daniel E. Ford, Rasheed Gbadegesin, Kathy Griendling, Katherine Hartmann, S. Susan Hedayati, Rebecca D. Jackson, Susan Matulevicius, Michael J. Mugavero, Eric J. Nehl, Tuhina Neogi, Judith G. Regensteiner, Michael A. Rubin, Doris Rubio, Kanakadurga Singer, Brownsyne Tucker Edmonds, Anna Volerman, Sandra Laney, Carrie Patton, Sindy Escobar Alvarez

×

Figure 1

Application process and funding committed to support biomedical researchers with family caregiving responsibilities.

Options: View larger image (or click on image) Download as PowerPoint
Application process and funding committed to support biomedical research...
(A) Application components typically included in the COVID-19 Fund to Retain Clinical Scientists (FRCS) program. Applicants must show strong evidence of research promise in an area that would advance medical science for a condition with significant clinical burden, evidence of pandemic-related family caregiving need, and commitment from their department. (B) Total funds committed from the Doris Duke Charitable Foundation, the COVID-19 FRCS Funding Collaborative members (American Heart Association, Burroughs Wellcome Fund, John Templeton Foundation, Rita Allen Foundation, and Walder Foundation), and matching institutional funds.